Lijun Sheng

479 total citations
19 papers, 283 citations indexed

About

Lijun Sheng is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lijun Sheng has authored 19 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lijun Sheng's work include Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Lung Cancer Research Studies (3 papers). Lijun Sheng is often cited by papers focused on Neuroendocrine Tumor Research Advances (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Lung Cancer Research Studies (3 papers). Lijun Sheng collaborates with scholars based in China, Canada and United Kingdom. Lijun Sheng's co-authors include Jihong Pan, Jianmei Wu, Jinxiang Han, Yahong Sun, Jian Liang, Ran He, Yafei Zhang, Yan Li, Haibo Liu and Yi Guo and has published in prestigious journals such as Journal of Clinical Oncology, ACM Computing Surveys and Neural Networks.

In The Last Decade

Lijun Sheng

17 papers receiving 279 citations

Peers

Lijun Sheng
Mengyang Li China
Mengping Long China
Huafeng Wang China
Yunseon Choi South Korea
Lanyun Feng China
Yulin Tan China
Niko Kemi Finland
Hao Hu China
Stuart Morton United States
Phillipe Taniere United Kingdom
Mengyang Li China
Lijun Sheng
Citations per year, relative to Lijun Sheng Lijun Sheng (= 1×) peers Mengyang Li

Countries citing papers authored by Lijun Sheng

Since Specialization
Citations

This map shows the geographic impact of Lijun Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijun Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijun Sheng more than expected).

Fields of papers citing papers by Lijun Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijun Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijun Sheng. The network helps show where Lijun Sheng may publish in the future.

Co-authorship network of co-authors of Lijun Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lijun Sheng. A scholar is included among the top collaborators of Lijun Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijun Sheng. Lijun Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sheng, Lijun, et al.. (2025). Out-of-Distribution Detection: A Task-Oriented Survey of Recent Advances. ACM Computing Surveys. 58(2). 1–39.
2.
3.
Sheng, Lijun, et al.. (2023). ProxyMix: Proxy-based Mixup training with label refinery for source-free domain adaptation. Neural Networks. 167. 92–103. 33 indexed citations
4.
Li, Zhenglin, et al.. (2023). Risk factors of early mortality in patients with small cell lung cancer: a retrospective study in the SEER database. Journal of Cancer Research and Clinical Oncology. 149(13). 11193–11205. 6 indexed citations
5.
Zhang, Weihua, et al.. (2021). Efficacy comparison between microwave ablation combined with radiation therapy and radiation therapy alone for locally advanced nonsmall-cell lung cancer. Journal of Cancer Research and Therapeutics. 17(3). 715–719. 7 indexed citations
6.
Chen, Ling, et al.. (2020). <p>Monoamine Oxidase A is a Major Mediator of Mitochondrial Homeostasis and Glycolysis in Gastric Cancer Progression</p>. Cancer Management and Research. Volume 12. 8023–8035. 21 indexed citations
7.
Cheng, Ying, Yun Fan, Xiaoqing Liu, et al.. (2019). Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first‑line therapy in patients with extensive‑stage small cell lung cancer. Oncology Letters. 17(5). 4701–4709. 7 indexed citations
8.
Wang, Yunchao, Tao Sun, Lijun Sheng, et al.. (2018). Overall Survival Benefit from Trastuzumab-Based Treatment in HER2-Positive Metastatic Breast Cancer: A Retrospective Analysis. Oncology Research and Treatment. 41(7-8). 450–455. 15 indexed citations
9.
Sheng, Lijun, et al.. (2017). The clinical utility and outcomes of microwave ablation for colorectal cancer liver metastases. Oncotarget. 8(31). 51792–51799. 26 indexed citations
10.
Sun, Yahong, et al.. (2015). Computed tomography-guided percutaneous microwave ablation therapy for lung cancer. Genetics and Molecular Research. 14(2). 4858–4864. 15 indexed citations
11.
12.
Sheng, Lijun, et al.. (2015). The crucial role of SRPK1 in TGF-β-induced proliferation and apoptosis in the esophageal squamous cell carcinomas. Medical Oncology. 32(7). 209–209. 21 indexed citations
13.
Sun, Yihong, Paul Y. Song, Y. Guo, et al.. (2015). Effects of microwave ablation or its combination with whole-body chemotherapy on serum vascular endothelial growth factor levels in patients with stage IIIB/IV NSCLC. Genetics and Molecular Research. 14(3). 10015–10025. 4 indexed citations
14.
Yang, Xiangshan, Daotang Li, Lijun Sheng, et al.. (2014). The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients. Tumor Biology. 35(11). 11091–11095. 13 indexed citations
15.
16.
17.
Wang, Zhehai, Jun Guo, Zhen Chen, et al.. (2008). [Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer].. PubMed. 30(5). 389–91. 1 indexed citations
18.
19.
Pan, Jihong, et al.. (2006). CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer. Acta Oncologica. 46(3). 361–366. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengyang Li Breakdown of academic impact, for papers by Mengping Long Breakdown of academic impact, for papers by Huafeng Wang Breakdown of academic impact, for papers by Yunseon Choi Breakdown of academic impact, for papers by Lanyun Feng Breakdown of academic impact, for papers by Yulin Tan Breakdown of academic impact, for papers by Niko Kemi Breakdown of academic impact, for papers by Hao Hu Breakdown of academic impact, for papers by Stuart Morton Breakdown of academic impact, for papers by Phillipe Taniere
Rankless by CCL
2026